High fructose intake during pregnancy increases insulin resistance (IR) and gestational diabetes mellitus (GDM) risk. IR during pregnancy primarily results from elevated hormone levels. We aim to determine the role of liver carbohydrate response element binding protein (ChREBP) in insulin sensitivity and lipid metabolism in pregnant mice and their offspring. Pregnant C57BL/6J wild-type mice and hepatocyte-specific ChREBP-deficient mice were fed with a high-fructose diet (HFrD) or normal chow diet (NC) pre-delivery. We found that the combination of HFrD with pregnancy excessively activates hepatic ChREBP, stimulating progesterone synthesis by increasing MTTP expression, which exacerbates IR. Increased progesterone levels upregulated hepatic ChREBP via the progesterone-PPARγ axis. Placental progesterone activated the progesterone-ChREBP loop in female offspring, contributing to IR and lipid accumulation. In normal dietary conditions, hepatic ChREBP modestly affected progesterone production and influenced IR during pregnancy. Our findings reveal the role of hepatic ChREBP in regulating insulin sensitivity and lipid homeostasis in both pregnant mice consuming an HFrD and female offspring, and suggest it as a potential target for managing gestational metabolic disorders, including GDM.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11014959PMC
http://dx.doi.org/10.1038/s44319-024-00121-wDOI Listing

Publication Analysis

Top Keywords

hepatic chrebp
16
female offspring
12
insulin resistance
8
pregnant mice
8
insulin sensitivity
8
sensitivity lipid
8
chrebp
5
liver chrebp
4
chrebp deficiency
4
deficiency inhibits
4

Similar Publications

Background: Intrahepatic lipid accumulation (IHL), a hallmark of metabolic disorders, is closely associated with de novo lipogenesis (DNL). Notably, fructose feeding increased the DNL. Lifestyle modifications resulting from dietary changes and increased physical activity/exercise can decrease the IHL content.

View Article and Find Full Text PDF
Article Synopsis
  • ChREBP is a key transcription factor that regulates genes involved in glucose, fructose, and lipid metabolism when carbohydrates are consumed, but its broader roles in metabolism need more research.* -
  • In a study using liver-specific gene silencing in rats on a high-fat/sugar diet, suppressing ChREBP resulted in lower short-chain acyl CoA metabolites and decreased free CoA levels, affecting various metabolic enzyme expressions.* -
  • Despite ChREBP knockdown enhancing fatty acid oxidation enzymes, the accumulation of liver acylcarnitines and ketones suggested a shift in metabolite processing, alongside maintained pyruvate levels due to increased transporter expression.*
View Article and Find Full Text PDF

Metabolic dysfunction-associated steatotic liver disease (MASLD) is a serious health problem, and recent evidence indicates that gut microbiota plays a key role in its development. It is known that 2-oleoyl glycerol (2-OG) produced by the gut microbiota is associated with hepatic fibrosis, but it is not known whether this metabolite is involved in the development of hepatic steatosis. The aim of this study was to evaluate how a high-fat-sucrose diet (HFS) increases 2-OG production through gut microbiota dysbiosis and to identify whether this metabolite modifies hepatic lipogenesis and mitochondrial activity for the development of hepatic steatosis as well as whether a combination of functional foods can reverse this process.

View Article and Find Full Text PDF

Dietary fructose regulates hepatic manganese homeostasis in female mice.

Heliyon

June 2024

NHC Key Laboratory of Hormones and Development, Tianjin Key Laboratory of Metabolic Diseases, Chu Hsien-I Memorial Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, China.

Arginase, an enzyme dependent on manganese (Mn), plays a crucial role in the production of urea and processing of ammonia in the liver. Previous studies have shown that overconsumption of fructose disrupts Mn homeostasis in the liver of male mice. However, the potential sex-specific differences in the impact of fructose on hepatic Mn homeostasis remain uncertain.

View Article and Find Full Text PDF

Hepatic glucokinase regulatory protein and carbohydrate response element binding protein attenuation reduce de novo lipogenesis but do not mitigate intrahepatic triglyceride accumulation in Aldob deficiency.

Mol Metab

September 2024

Department of Internal Medicine, Division of Endocrinology and Metabolic Disease, Maastricht University Medical Center+, Maastricht, the Netherlands; Department of Internal Medicine, CARIM, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, the Netherlands; Department of Internal Medicine, CARIM, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht University Medical Center+, Maastricht, the Netherlands. Electronic address:

Article Synopsis
  • The study investigates how fructose 1-phosphate (F1P) influences the process of de novo lipogenesis (DNL) in the liver, specifically focusing on two regulators: glucokinase regulatory protein (GKRP) and carbohydrate response element binding protein (ChREBP).
  • Aldolase B deficient mice, which show increased F1P levels and DNL, were used to assess the effects of manipulating GKRP and ChREBP on lipid synthesis.
  • Results indicated that while knocking out GKRP reduced palmitate synthesis, knocking down ChREBP normalized enzyme expression involved in DNL, highlighting their roles in regulating liver fat accumulation, despite no change in triglyceride levels.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!